2025 Impact Factor: 7.6 - Top 15% (Q1 in ONCOLOGY); CiteScore 2025: 10.3 - Top 8% (Q1 in Pharmacology). Indexed in PubMed Central(PMC), ESCI and Scopus #Cancer
Beijing, China
Joined September 2020
- Tweets1.6K
- Following3K
- Followers859
- Likes1K
Cancer Drug Resistance retweeted
Very pleased to share our review just published in @cdrjournal from #LegorretaCancerCenter @BrownUCancer @BrownMedicine @BrownUnivHealth @BrownPathology @MSMEDU “Acquired resistance to molecularly targeted therapies for cancer” oaepublish.com/articles/cdr.…
Cancer Drug Resistance retweeted
📢 Upcoming Webinar:
🌍 Theme: #Brain-#Gut-#Microbiota Axis: Implications for #Psychiatry
📅 [13:00 (GMT) March 24, 2025] 📍 [Online]
🔗 Register now: (Limited seats—secure yours now!)[oaepublish.com/webreviewer/m…]
🎤Featured Speaker: Prof. @TedDinan
🎤 Moderator: @microbetracker
Cancer Drug Resistance retweeted
@cdrjournal partnered with the EMBO | EMBL Symposium -The aging genome: from
mechanisms to disease.， which will be held on 10-13 June 2025.
Learn more: reurl.cc/L5Knr3
#research #cancer #cell #openaccess
Cancer Drug Resistance retweeted
🥳🥳We are delighted to have a special interview with Prof. Gregor Reid, a Distinguished Professor Emeritus at #WesternUniversity, Fellow of the Royal Society of Canada, and 2024 Highly Cited Researcher.
Watch the following video for insights from him:👇
oaepublish.com/interviews/mr…
Cancer Drug Resistance retweeted
ecDNA are rogue genetic material that amplify genes, contribute to treatment resistance and drive genomic heterogeneity. We report on the Origins and impact of extrachromosomal DNA today in @Nature nature.com/articles/s41586-0…
Cancer Drug Resistance retweeted
At Cal Cancer Consortium conference, Jonathan Riess shows impact of baseline positive vs negative plasma ctDNA for EGFR in the FLAURA2 trial. Addition of chemo to Osi mainly benefitting those with positive ctDNA. Food for thought! @UCD_Cancer @cityofhope @UCenter60768
Cancer Drug Resistance retweeted
🌟Great news！
We are excited to announce that #Microbiome Research Reports (#MRR) has been officially accepted for inclusion in the Emerging Sources Citation Index (#ESCI, Web of Science) as of Aug 7, 2024. MRR’s first impact factor is coming in June 2025!👏
Welcome to share!
Cancer Drug Resistance retweeted
PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway
nature.com/articles/s41419-0…
Cancer Drug Resistance retweeted
🧠Neuron-derived extracellular vesicles isolation by GAP43 and NLGN3 immunocapture offers a robust novel platform for biomarker development in Alzheimer’s disease. ✏️By Erez Eitan and Dimitrios Kapogiannis, et al.
📔Read at: oaepublish.com/articles/evcn…
Cancer Drug Resistance retweeted
2023 Liquid biopsy EQA for lung cancer (EGFR) webinar - recorded 27th June 2024
m.youtube.com/watch?v=zYz0Dz…
Cancer Drug Resistance retweeted
Congratulations to Dr. Ruicheng Wu for this sizable summary work.🥳🥳
Three-Dimensional Printing Creates New Trends of the Technological Revolution in Urologic Surgery | ACS Materials Letters pubs.acs.org/doi/10.1021/acs…
Cancer Drug Resistance retweeted
"We have seen that RNF144B plays an important role in cancer processes, because, although p53, the tumor suppressor gene par excellence, is intact, the alterations in RNF144B are sufficient to induce the formation of tumors in tissues like the lung.”
medicalxpress.com/news/2024-…
Cancer Drug Resistance retweeted
The 2024 Journal Citation Reports is coming soon! More than 21,800 trusted journals will receive a Journal Impact Factor. Join the conversation using #JCR2024 and #TrustedJournals.
Cancer Drug Resistance retweeted
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms
onlinelibrary.wiley.com/doi/…
Cancer Drug Resistance retweeted
Efficiency of bladder-sparing strategies for bladder cancer: an umbrella review - the first umbrella review from my team🥳
journals.sagepub.com/doi/10.…
Cancer Drug Resistance retweeted
Share our new paper. Feng, DC.et al. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy. Military Med Res 11, 21 (2024). doi.org/10.1186/s40779-024-0…
Cancer Drug Resistance retweeted
🤗Share with you the latest publication from our Junior Editor---Prof. Tingtao Chen
#Vaginalmicrobiota: Potential targets for #vulvovaginal #candidiasis infection
🤟Published on 2 March 2024
View the full text: 👇doi.org/10.1016/j.heliyon.20…
#Probiotics #Postbiotics #Synbiotic
Cancer Drug Resistance retweeted
Teaching an old dog new tricks: ABCB1 actionable target to combat paclitaxel resistance in PDAC by Bergonzini et al. in Amsterdam Leiden Pisa
jeccr.biomedcentral.com/arti…
pubmed.ncbi.nlm.nih.gov/3816…
Thanks to @kwf_nl @CancerCenterAms #FPS @AIRC_it @EORTC for the support and collaboration
Cancer Drug Resistance retweeted
@MMR_Journal @Research_Jrnl @iMetaScience @cdrjournal @Phenomics_J @ISOAD2018 Welcome your contributions to these potent journals.
Cancer Drug Resistance retweeted
Honored to share our insights in such prestigious journal. Re: Immune System and Intestinal Microbiota Determine Efficacy of Androgen Deprivation Therapy Against Prostate Cancer - European Urology europeanurology.com/article/…